TheraVet S.A (ALVET) | Stock Overview & Key Data
TheraVet S.A Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: €8.56 on June 21, 2021
Explore how other French stocks compare to their 52-week ranges: View FR Market 52-Week Insights
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
TheraVet S.A
ALVET
|
N/A | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -89.74% | -98.11% | -99.02% | -99.02% | -99.02% | -99.02% |
|
Covivio S.A
COV
|
6.28B Large-cap | 3.86% | 3.95% | -3.92% | 1.85% | -1.34% | 7.84% | 19.10% | -27.72% | -30.18% | 5.66% | 5.66% |
|
Dbv Technologies
DBV
|
1.02B Large-cap | 12.32% | -4.78% | -7.80% | 2.24% | -2.45% | 89.31% | -17.08% | -70.89% | -94.37% | -62.38% | -62.38% |
| 108.28M Small-cap | 0.00% | -10.92% | 43.52% | 43.52% | 43.52% | 41.82% | 41.82% | 41.82% | 41.82% | 41.82% | 41.82% | |
|
Inventiva S.A
IVA
|
980.10M Mid-cap | -4.11% | -32.02% | -36.99% | -12.10% | -19.26% | 17.12% | -17.79% | -71.83% | -58.75% | -58.75% | -58.75% |
|
Ose
OSE
|
70.48M Small-cap | 12.39% | -26.38% | 29.55% | 29.55% | 29.55% | 27.96% | 27.96% | 27.96% | 27.96% | 27.96% | 27.96% |
Calculate Your TheraVet S.A Investment Returns
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is ALVET's 52-week high and low?
- In the last 52 weeks, TheraVet S.A reached a high of €0.79 (on N/A) and a low of €0.06 (on November 26, 2024).
- What is the market cap and P/E ratio for ALVET?
- Curious about TheraVet S.A's size and valuation? Its market capitalization stands at N/A. When it comes to valuation, the P/E ratio (trailing twelve months) is N/A, and the forward P/E (looking ahead) is N/A.
- Does ALVET pay dividends? If so, what's the yield?
- As for dividends, TheraVet S.A isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are TheraVet S.A's main competitors or similar companies to consider before investing?
When looking at TheraVet S.A, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Covivio S.A
COV6.28B Real Estate REIT - Diversified 7.84% 19.10% Dbv Technologies
DBV1.02B Healthcare Biotechnology 89.31% -17.08% Innate Pharma S.A
IPH108.28M Healthcare Biotechnology 41.82% 41.82% Inventiva S.A
IVA980.10M Healthcare Biotechnology 17.12% -17.79% Ose
OSE70.48M Healthcare Biotechnology 27.96% 27.96% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for TheraVet S.A.? (e.g., ROE, Debt/Equity)
- To get a sense of TheraVet S.A's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is N/A, the Debt to Equity ratio from the most recent quarter is N/A, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for ALVET?
- Looking at TheraVet S.A's growth, its revenue over the trailing twelve months (TTM) was N/A. Compared to the same quarter last year (YoY), quarterly revenue grew by N/A, and quarterly earnings saw a YoY growth of N/A.
- How much of ALVET stock is held by insiders and institutions?
- Wondering who owns TheraVet S.A stock? Company insiders (like executives and directors) hold about N/A of the shares, while institutional investors (such as mutual funds and pension funds) own approximately N/A.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.